Resultado de búsqueda
Dana-Farber Cancer Institute in Boston, MA, is a world leader in adult and pediatric cancer treatment and research. Our oncologists and cancer researchers practice and develop some of the most advanced cancer treatments in the world.
- COVID-19 Facts and Resources
Wearing a face mask at Dana-Farber is currently optional if...
- For Patients and Families
Through a long-standing collaboration between Dana-Farber...
- Our Research
At Dana-Farber, scientists are attacking cancer at every...
- About Us
Since its founding in 1947, Dana-Farber Cancer Institute in...
- Inclusion, Diversity, and Equity
Dana-Farber Cancer Institute Launches Neuro-Inclusive...
- Appointments & Second Opinions
Since 1947, Dana-Farber's sole focus has been to provide...
- How You Can Help
Run any race, of any distance, in any city, or join an...
- Therapies and Vaccines
Thomas Farrington, a prostate cancer survivor and founder of...
- COVID-19 Facts and Resources
The Dana–Farber/Harvard Cancer Center is the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation. Founded in 1997, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard affiliated community.
- Private
- 450 Brookline Avenue, Boston, Massachusetts, United States
Since 1947, Dana-Farber Cancer Institute has been providing expert cancer care and groundbreaking treatments for adult and pediatric patients. U.S. News and World Report consistently ranks Dana-Farber as the #1 cancer hospital in New England, and among the best in the nation.
Learn about the comprehensive cancer care and research at Dana-Farber Cancer Institute, and what sets us apart from other cancer centers.
Dana-Farber Cancer Institute is a founding member of DF/HCC, established in Boston in 1947 under the leadership of Dr. Sidney Farber, the father of modern chemotherapy, and one of the first to become an NCI-Designated Comprehensive Cancer Center in 1973. Focused equally on cancer research and care, DF/HCC’s mission is to provide expert ...